XTNTXtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for ce…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ... Despite a challenging quarter with declining revenue and margins, Xtant is positioning for growth through the Dillon integration and new product launches targeting a $7.5 billion market. | ||
 Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary Moby summary of Xtant Medical Holdings, Inc.'s Q2 2026 earnings call | ||
 Xtant Medical Q1 Earnings Call Highlights Xtant Medical (NYSEAMERICAN:XTNT) raised its full-year 2026 revenue guidance after announcing a distribution agreement that moves the company into the hemostatic agent market, while first-quarter revenue declined from the prior-year period following divestitures and the loss of certain license reven | ||
 Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary Moby summary of Xtant Medical Holdings, Inc.'s Q1 2026 earnings call | ||
Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ... Xtant Medical Holdings Inc (XTNT) reports a revenue decline but strengthens its market position with strategic initiatives and product launches. | ||
 Xtant Medical Hldgs Q1 2026 Earnings Call Transcript Xtant Medical Hldgs (AMEX:XTNT) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. The full earnings call is available at https://www.webcaster5.com/Webcast/Page/3039/53872 Summary Xtant Medical Holdings Inc reported first quarter 2026 revenue of $20.9 million, a decrease from the previous y | ||
 3 Promising Penny Stocks With Market Caps Under $200M Over the last 7 days, the market has remained flat, yet it is up 28% over the past year with earnings forecasted to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for growth at lower price points, especially when backed by strong balance sheets and solid fundamentals. This article explores several penny stocks that stand out as hidden gems, potentially offering both stability and upside in today's market landscape. | ||
Xtant Medical Holdings Inc (XTNT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... Xtant Medical Holdings Inc (XTNT) reports a significant turnaround with increased revenue and profitability, driven by innovative product launches and strategic focus on high-margin biologics. | ||
Xtant Medical Holdings, Inc. Q4 2025 Earnings Call Summary Moby summary of Xtant Medical Holdings, Inc.'s Q4 2025 earnings call | ||
Xtant Medical Q4 Earnings Call Highlights Xtant Medical (NYSEAMERICAN:XTNT) reported fourth-quarter and full-year 2025 results highlighting modest quarterly revenue growth, improved profitability, and a sharper strategic focus following the sale of non-core assets to Companion Spine. Fourth-quarter results show revenue growth and continued | ||